What is the average age of onset for macular Telangiectasia Type 2?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Average Age of Onset for Macular Telangiectasia Type 2

The average age of onset for Macular Telangiectasia Type 2 (MacTel 2) is typically between 50 and 69 years of age, with the majority of patients (76%) becoming symptomatic during the sixth or seventh decade of life. 1

Epidemiology and Age Distribution

Macular Telangiectasia Type 2 is an acquired bilateral neurodegenerative macular disease that typically manifests during middle age. The specific age distribution shows:

  • 58% of patients become symptomatic before age 60 1
  • The highest frequency of symptom onset (76%) occurs between ages 50-69 1
  • The disease usually manifests during the fourth to sixth decades of life 2

Clinical Presentation and First Symptoms

The initial presentation of MacTel 2 is characterized by specific symptoms that help identify the condition:

  • Reading difficulty is the most common first symptom (79% of patients) 1
  • Metamorphopsia (visual distortion) is the second most common initial symptom (12%) 1
  • The disease is often asymptomatic in early stages, making detection challenging without careful fundus examination

Disease Characteristics

MacTel 2 has distinct features that differentiate it from other macular conditions:

  • Bilateral involvement is typical
  • Minimal dilatation of parafoveal capillaries with graying of the affected retinal area
  • Lack of lipid exudation
  • Right-angled retinal venules
  • Refractile deposits in the superficial retina
  • Hyperplasia of the retinal pigment epithelium
  • Foveal atrophy
  • Potential development of subretinal neovascularization in advanced stages 2, 3

Diagnostic Considerations

Diagnosis of MacTel 2 has historically been delayed, with a median delay of:

  • 7 years before 2005
  • 1 year after 2005 (due to improved awareness and diagnostic techniques) 1

Visual Prognosis

Ten years after symptom onset, visual acuity outcomes vary:

  • 35% of patients maintain good distance visual acuity (≥20/25) in their better eye
  • 17% experience moderate to severe visual impairment (≤20/50) 1

Diagnostic Imaging

Multiple imaging modalities help confirm the diagnosis:

  • Fluorescein angiography: Shows deep intraretinal hyperfluorescent leakage, typically beginning in the temporal parafoveal area
  • Optical coherence tomography (OCT): Reveals intraretinal hyporeflective spaces not associated with retinal thickening
  • Fundus autofluorescence: Demonstrates characteristic macular pigment depletion 3, 4

The prevalence of MacTel 2 may be underestimated and has been reported to be as high as 0.1% in persons 40 years and older 5, making awareness of its typical age of onset important for timely diagnosis and management.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.